🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Had a jolly good time bringing holiday cheer to team members, patients and friends Moffitt Cancer Center today! Thank you to #TheReMissions and all our special guest singers who joined in for the fun. ❄️🎁🎄 Here’s our cover of “All I Want for Christmas is You!”

#NiemannPick Disease Type C is a rare, fatal and progressive genetic disorder characterized by a defect in the #NPC1 protein. Learn more: bit.ly/3xg1ig8 $CYTH

MEMBER NEWS: ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering. View full news release: investors.zyversa.com/news-releases/… ZyVersa Therapeutics

Learn more about our oral and poster presentations at #ASH23. NeoGenomics: Leading the way in heme cancer testing with groundbreaking insights. #ASH23 #Hematology #NeoGenomics #HemeCancers

Join NeoGenomics at #ASH23, booth #851, to uncover the latest breakthroughs shaping the future of heme oncology testing. #NeoGenomics #ASH23

Reminder: Spring 2024 term starts Mon., Jan. 8, 2024. Register today to secure your classes now. Share this with someone who could use a reminder. palmbeachstate.edu/getstarted/def… #MyPBSC

This Thursday! Reg today: bioflorida.com/events/EventDe…

In a new study published in Nature Communications, Moffitt Cancer Center researchers report on the identification of a cell signaling pathway that regulates the metastatic spread of #melanoma cells to the brain. Keiran Smalley moffitt.org/newsroom/news-…

Live from #ASH23: Drs. Rami komrokji and Jeffrey Lancet discuss the emerging clinical evidence in the treatment and management of myelodysplastic syndrome. #MoffittASH23

Over the last 20 years, we've contributed to talent development, entrepreneurship, and communities. Take a look at our Impact Report. 👉 globant.link/41f0A17 #Globant20 #GlobantImpact

Idan is our little hero who faced a rare immune disorder at eight months old. 🦸‍♂️ Thanks to Alex, who donated his blood stem cells, Idan is now thriving! ⌛Help us create more stories like Idan's—donate on our website: bit.ly/3GqPzAh #CureBloodCancer #SavingLives

A remarkable second WIO Summit at Exactech! This weekend was a celebration of women who are revolutionizing ortho through their achievements & community. Through diversity, equity & inclusion, this field knows no boundaries. 👩‍⚕️🌟 #orthopaedics #ExacWomenInOrtho #medicaleducation

(1/2) NeoGenomics is thrilled to announce a recently published paper in Clinical Cancer Research highlighting our MultiOmyx™ technology. Our colleague Qingyan 'Sandy' Au PhD and collaborator Ken Young, MD, Duke University Medical Center co-presented at the American Society of

Future innovators found a home at #Arthrex this weekend! We were proud to host a robotics competition for FIRST Tech Challenge (part of the global nonprofit FIRST). Students worked in teams to design, build and code robots, developing STEM skills and learning engineering principles.

MEMBER NEWS: The University of Florida, Concept Companies, and Trimark Properties Join Forces To Make Gainesville's Innovation District a Major Economic Hub. Read news: innovate.research.ufl.edu/2023/12/08/uf-… FLORIDA UF Innovate

MEMBER NEWS: The University of Florida, Concept Companies, and Trimark Properties Join Forces To Make Gainesville's Innovation District a Major Economic Hub. Read the news: innovate.research.ufl.edu/2023/12/08/uf-…

The FDA feedback we received allows us to proceed as planned to bring a potential treatment option to this underserved patient community. bit.ly/3NsbJFZ $CYTH #NiemannPick #NPC1

MEMBER NEWS: ZyVersa Therapeutics Engages CRO, George Clinical, for Phase 2a Clinical Trial for Cholesterol Efflux Mediator VAR 200. View full news release: investors.zyversa.com/news-releases/…

Tonight on the winter solstice, #TheLongestDay participants across the country will display luminaries 🕯️ in windows and doorsteps to raise Alzheimer's awareness. We thank all of them for sharing why they're fighting to #ENDALZ. #WinterSolstice.

MEMBER NEWS: ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older. View full news release: ir.admabiologics.com/news-releases/…